Effectiveness of BNT162b2 after extending the primary series dosing interval in children and adolescents aged 5–17

[1]  Anonymous.  Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada , 2023, Clinical Infectious Diseases.

[2]  K. Khunti,et al.  Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex , 2022, Circulation.

[3]  M. Bertrand,et al.  Age and sex-specific risks of myocarditis and pericarditis following Covid-19 messenger RNA vaccines , 2022, Nature Communications.

[4]  C. Siu,et al.  Thromboembolic events and hemorrhagic stroke after mRNA (BNT162b2) and inactivated (CoronaVac) covid-19 vaccination: A self-controlled case series study , 2022, eClinicalMedicine.

[5]  D. Skowronski,et al.  SARS-CoV-2 mRNA Vaccine Effectiveness in Health Care Workers by Dosing Interval and Time Since Vaccination: Test-Negative Design, British Columbia, Canada , 2022, Open forum infectious diseases.

[6]  Xia Li,et al.  Impact of a delayed second dose of mRNA vaccine (BNT162b2) and inactivated SARS-CoV-2 vaccine (CoronaVac) on risks of all-cause mortality, emergency department visit, and unscheduled hospitalization , 2022, BMC Medicine.

[7]  P. Ip,et al.  Adverse events of special interest following the use of BNT162b2 in adolescents: a population-based retrospective cohort study , 2022, Emerging microbes & infections.

[8]  Y. Lau,et al.  Myocarditis Following COVID-19 BNT162b2 Vaccination Among Adolescents in Hong Kong , 2022, JAMA pediatrics.

[9]  V. Kulasingam,et al.  Delayed-interval BNT162b2 mRNA COVID-19 vaccination enhances humoral immunity and induces robust T cell responses , 2022, Nature Immunology.

[10]  P. Moss.  The T cell immune response against SARS-CoV-2 , 2022, Nature Immunology.

[11]  E. Wan,et al.  Multimorbidity and adverse events of special interest associated with Covid-19 vaccines in Hong Kong , 2022, Nature Communications.

[12]  I. Hung,et al.  Post‐Covid‐19‐vaccination adverse events and healthcare utilization among individuals with or without previous SARS‐CoV‐2 infection , 2022, Journal of internal medicine.

[13]  H. Whitaker,et al.  Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England , 2021, Nature Communications.

[14]  C. Fjell,et al.  Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada , 2021, medRxiv.

[15]  E. Wan,et al.  Two-dose COVID-19 vaccination and possible arthritis flare among patients with rheumatoid arthritis in Hong Kong , 2021, Annals of the Rheumatic Diseases.

[16]  Rosalind J Wright,et al.  Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine , 2021, Cell.

[17]  A. Robicsek,et al.  Myocarditis and Pericarditis After Vaccination for COVID-19. , 2021, JAMA.

[18]  Sm,et al.  Myocarditis After mRNA COVID-19 Vaccine , 2021 .

[19]  M. Davenport,et al.  Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection , 2021, Nature Medicine.

[20]  Juan Jorge Huamán Saavedra,et al.  SARS-COV-2 variants , 2021, Revista Médica de Trujillo.

[21]  Elisabeth Mahase.  Covid-19: Assess the effects of extending Pfizer vaccine dosing interval, expert urges , 2021, British medical journal.

[22]  OUP accepted manuscript , 2021, Clinical Infectious Diseases.

[23]  Melis N. Anahtar,et al.  Clinical sensitivity and interpretation of PCR and serological COVID‐19 diagnostics for patients presenting to the hospital , 2020, medRxiv.

[24]  S. Kellie,et al.  A self-controlled case series study of the temporal relationship between acquisition of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and subsequent MRSA bacteremia , 2015 .

[25]  W. Chan,et al.  The ecology of health care in Hong Kong. , 2005, Social science & medicine.

[26]  M. Burns,et al.  Case-Control Study , 2020, Definitions.